Poseida Therapeutics, Inc. Temporary Equity, Carrying Amount, Attributable to Parent
Poseida Therapeutics, Inc. had Temporary Equity, Carrying Amount, Attributable to Parent of $326.31 million as of 2020-07-14, per its 10-K filed 2022-03-10.
Discontinued › Balance Sheet › Temporary Equity
us-gaap:TemporaryEquityCarryingAmountAttributableToParent · last filed 2022-03-10
- 2020-07-14: Temporary Equity, Carrying Amount, Attributable to Parent $326.31M.
- 2020-06-30: Temporary Equity, Carrying Amount, Attributable to Parent $326.31M.
- 2019-12-31: Temporary Equity, Carrying Amount, Attributable to Parent $222.17M.
| Period end | Temporary Equity, Carrying Amount, Attributable to Parent |
|---|---|
| 2020-07-14 | $326.31M 10-K · filed 2022-03-10 |
| 2020-06-30 | $326.31M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $222.17M 10-K · filed 2021-03-11 |